Metabolon Expands Microbiome Panel to Strengthen Industry Leadership in Functional Microbiome Research

Enhanced panel screens for more than 800 microbiome-associated metabolites, giving researchers a broader view of microbial activity linked to human health, nutrition, disease, and treatment response. MORRISVILLE, N.C., July 15, 2026 — Metabolon, Inc., the global leader in metabolomics solutions advancing life science research, diagnostics, therapeutics, and precision medicine, today announced an expansion of its Microbiome Panel, further strengthening the company’s position in one of the fastest-growing areas of multiomic research. The enhanced Microbiome Panel enables researchers to screen fo